Nusano
  • Company
    • Leadership
    • Medical Iso Advisory Board
    • Strategic Advisory Board
    • Mission & Values
    • West Valley City
    • Contact Us
  • Technology
  • Batteries
  • Energy
    • HALEU
    • Nuclear Fuel Cycle
  • Industrial
  • Life Sciences
    • Medical Isotopes
    • Request Quote
    • R&D Collaboration
    • About Nuclear Med
  • News
    • Press Releases
    • Video
    • Podcast
    • Email Sign Up
  • Careers
    • Current Openings
    • Life in Utah
Select Page
Nusano and GlyTherix Announce Lutetium-177 Supply Agreement

Nusano and GlyTherix Announce Lutetium-177 Supply Agreement

by Scott Larrivee | Dec 9, 2024 | News

VALENCIA, Calif. and SYDNEY, Australia – Dec. 9, 2024 – Nusano, a physics company transforming the production of radioisotopes, and GlyTherix Ltd (GlyTherix) an Australian targeted radiotherapy company specializing in developing antibody radiopharmaceuticals for solid...

Recent Posts

  • Nusano Announces September 2025 Conference Schedule
  • Photo Gallery: Production Facility Ribbon Cutting
  • Nusano Cuts Ribbon on State-of-the-Art Radioisotope Production Facility
  • Nusano Establishes Strategic Advisory Board to Support Innovation Across Company’s Product Verticals
  • Nusano Achieves Key Technology Milestone Enabling Simultaneous Production of Multiple Radioisotopes

Recent Comments

No comments to show.
Nusano
Supplying the fight against cancer & enabling life-changing innovations
  • Follow
  • Follow
  • Follow
Company
about us
Leadership
Contact us
technology

The Nusano Platform
R&D Collaboration

Resources
News
Careers
Suppliers
© 2025 Nusano | Web design
Privacy Policy – Terms of Service